Literature DB >> 9270038

Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression.

S Saporta1, D F Cameron, C V Borlongan, P R Sanberg.   

Abstract

The use of cyclosporine-A (CsA) immunosuppression for neural transplantation has become the treatment of choice for ameliorating host-graft rejection responses in human and animal transplant studies. However, the cytotoxic effects of CsA have warranted a search for alternative methods of protecting neural transplants. Sertoli cells produce an immunosuppressant factor, Fas ligand (Fas-L), that may provide the testis with its immunoprivileged status. Therefore, it has recently been suggested that these cells may be useful in producing localized immunosuppression for transplants. If Sertoli cells do produce localized immunosuppression, then it should be possible to successfully transplant Sertoli cells without additional immunosuppression following transplant surgery. The present study was undertaken to determine whether rat or porcine Sertoli cells transplanted into rat brain would survive for an extended period of time without CsA immunosuppression. Isolated rat or porcine Sertoli cells prelabeled with DiI were transplanted into normal rat brain. We report that both rat Sertoli cell allografts and porcine Sertoli cell xenografts survived for at least 2 months posttransplantation into the rat brain without CsA immunosuppression, indicating that these grafts were capable of producing sufficient localized immunosuppression to survive at the site of transplant without additional systemic immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270038     DOI: 10.1006/exnr.1997.6493

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  16 in total

Review 1.  Treating childhood traumatic brain injury with autologous stem cell therapy.

Authors:  Shyam Dewan; Samantha Schimmel; Cesar V Borlongan
Journal:  Expert Opin Biol Ther       Date:  2018-02-15       Impact factor: 4.388

Review 2.  Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.

Authors:  Connor Stonesifer; Sydney Corey; Shaila Ghanekar; Zachary Diamandis; Sandra A Acosta; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2017-07-23       Impact factor: 11.685

3.  Delivery of a therapeutic protein by immune-privileged Sertoli cells.

Authors:  Katelyn Halley; Emily L Dyson; Gurvinder Kaur; Payal Mital; Peter M Uong; Brinda Dass; Sherry N Crowell; Jannette M Dufour
Journal:  Cell Transplant       Date:  2010-08-17       Impact factor: 4.064

4.  Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study.

Authors:  Alba I Rodriguez; Alison E Willing; Samuel Saporta; Don F Cameron; Paul R Sanberg
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

5.  Immature and neurally differentiated mouse embryonic stem cells do not express a functional Fas/Fas ligand system.

Authors:  Gabriella Brunlid; Jan Pruszak; Benjamin Holmes; Ole Isacson; Kai-Christian Sonntag
Journal:  Stem Cells       Date:  2007-07-05       Impact factor: 6.277

6.  Neurobehavioral assessment of transplanted porcine Sertoli cells into the intact rat striatum.

Authors:  Alba I Rodríguez; Alison E Willing; Don F Cameron; Samuel Saporta; Paul R Sandberg
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

Review 7.  The battle of the sexes for stroke therapy: female- versus male-derived stem cells.

Authors:  Yuji Kaneko; Travis Dailey; Nathan L Weinbren; Jessica Rizzi; Cyrus Tamboli; Julie G Allickson; Nicole Kuzmin-Nichols; Paul R Sanberg; David J Eve; Naoki Tajiri; Cesar V Borlongan
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

8.  Genetically engineered immune privileged Sertoli cells: A new road to cell based gene therapy.

Authors:  Gurvinder Kaur; Charles R Long; Jannette M Dufour
Journal:  Spermatogenesis       Date:  2012-01-01

9.  An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside.

Authors:  Travis Dailey; Christopher Metcalf; Yusef I Mosley; Robert Sullivan; Kazutaka Shinozuka; Naoki Tajiri; Mibel Pabon; Sandra Acosta; Yuji Kaneko; Harry van Loveren; Cesar V Borlongan
Journal:  J Clin Med       Date:  2013-12       Impact factor: 4.241

Review 10.  Adult stem cell transplantation: is gender a factor in stemness?

Authors:  Naoki Tajiri; Kelsey Duncan; Mia C Borlongan; Mibel Pabon; Sandra Acosta; Ike de la Pena; Diana Hernadez-Ontiveros; Diego Lozano; Daniela Aguirre; Stephanny Reyes; Paul R Sanberg; David J Eve; Cesar V Borlongan; Yuji Kaneko
Journal:  Int J Mol Sci       Date:  2014-08-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.